Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination

Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination

Despite current therapeutic strategies for immunomodulation and relief of symptoms in multiple sclerosis (MS), remyelination falls short due to dynamic neuropathologic deterioration and relapses, leading to accrual of disability and associated patient dissatisfaction. The potential of cannabinoids i...

Full description

Bibliographic Details
Main Authors: Victor Longoria, Hannah Parcel, Bameelia Toma, Annu Minhas, Rana Zeine
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Biomedicines
Subjects:
medical marijuana
cannabinoids
cannabidiol (CBD)
delta-9-tetrahydrocannabinol (Δ<sup>9</sup>-THC)
multiple sclerosis (MS)
experimental autoimmune encephalomyelitis (EAE)
Online Access:https://www.mdpi.com/2227-9059/10/3/539

Internet

https://www.mdpi.com/2227-9059/10/3/539

Similar Items